A. Madejón

发表

Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry.

C. Stephens, R. Andrade, N. Kaplowitz, 2021, Journal of hepatology.

Herbal and Dietary Supplement‐Induced Liver Injuries in the Spanish DILI Registry

C. Stephens, R. Andrade, M. L. de la Mata, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus

A. Fontanet, S. Pol, M. Albert, 2018, Gut.

Influence of a single nucleotide polymorphism at the main ribavirin transporter gene on the rapid virological response to pegylated interferon-ribavirin therapy in patients with chronic hepatitis C virus infection.

V. Soriano, S. Rodríguez-Nóvoa, I. Jiménez-Nácher, 2010, The Journal of infectious diseases.

Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C

V. Soriano, J. González-lahoz, S. Rodríguez-Nóvoa, 2010, Antimicrobial Agents and Chemotherapy.

Emerging drugs for hepatitis C

V. Soriano, J. Sheldon, J. García-Samaniego, 2008 .

Effects of delayed freezing of liver biopsies on the detection of hepatitis C virus RNA strands.

V. Carreño, A. Madejón, I. Castillo, 2000, Journal of hepatology.

Hepatitis B and D genomes in hepatitis B surface antigen negative patients with chronic hepatitis C

J. Bartolomé, V. Carreño, A. Madejón, 1995, Journal of medical virology.

One‐quarter of chronic hepatitis D patients reach HDV‐RNA decline or undetectability during the natural course of the disease

M. Buti, R. Esteban, S. Lens, 2021, Alimentary pharmacology & therapeutics.

Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment

R. Mena, A. Olveira, J. García-Samaniego, 2019, World journal of gastroenterology.

Short communication: transmission of hepatitis B viruses with lamivudine resistance mutations in newly diagnosed HIV individuals.

V. Soriano, J. del Romero, C. de Mendoza, 2009, AIDS research and human retroviruses.

Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B

M. Buti, M. Miquel, P. Cordero, 2023, Digestive Diseases and Sciences.

Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.

E. Domingo, M. Buti, R. Macenlle, 2019, Antiviral research.

Hepatitis B, C, and D and HIV infections among immigrants from Equatorial Guinea living in Spain.

E. Poveda, V. Soriano, C. de Mendoza, 2013, The American journal of tropical medicine and hygiene.

Detection of hepatitis B virus genotype A3 and primary drug resistance mutations in African immigrants with chronic hepatitis B in Spain.

V. Soriano, J. García-Samaniego, A. Madejón, 2011, The Journal of antimicrobial chemotherapy.

Community Strategy for Hepatitis B, C, and D Screening and Linkage to Care in Mongolians Living in Spain

M. Buti, A. Palom, J. García-Samaniego, 2023, Viruses.

Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations

V. Soriano, J. García-Samaniego, A. Madejón, 2009, Journal of viral hepatitis.

Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy

Pablo Barreiro, Pablo Rivas, V. Soriano, 2010, Antiviral therapy.

High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods

E. Domingo, M. Buti, M. Álvarez-Tejado, 2014, Journal of Clinical Microbiology.

Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patients.

V. Soriano, I. Jiménez-Nácher, S. Resino, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity

D. Subirá, A. Olveira, J. García-Samaniego, 2017, Journal of Virology.

Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype.

A. Olveira, J. García-Samaniego, A. Madejón, 2016, World journal of gastroenterology.

Natural Polymorphisms Associated with Resistance to New Antivirals against HCV in Newly Diagnosed HIV–HCV-Coinfected Patients

E. Poveda, V. Soriano, J. del Romero, 2011, Antiviral therapy.

Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV‐coinfected patients

V. Soriano, S. Rodríguez-Nóvoa, I. Jiménez-Nácher, 2011, Journal of viral hepatitis.

In vitro characterisation and clinical evaluation of the diagnostic accuracy of a new antigen test for SARS-CoV-2 detection.

P. Castán, J. Rubio, A. Madejón, 2021, medRxiv.

In vitro characterization and clinical evaluation of the diagnostic accuracy of a new antigen test for SARS-CoV-2 detection

J. M. Rubio, P. Castán, A. Madejón, 2021 .

GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic hepatitis B, C, and D.

V. Carreño, A. Madejón, M. Pardo, 1997, Gastroenterology.

Elevation of Liver Fibrosis Index FIB-4 Is Associated With Poor Clinical Outcomes in Patients With COVID-19

J. Calleja, A. Albillos, R. Bañares, 2020, The Journal of infectious diseases.

Treatment of chronic hepatitis D virus infection with low and high doses of interferon‐α2a: Utility of polymerase chain reaction in monitoring antiviral response

J. Bartolomé, V. Carreño, I. Castillo, 1994, Hepatology.

Emerging drugs for hepatitis C.

V. Soriano, J. Sheldon, J. García-Samaniego, 2008, Expert opinion on emerging drugs.

In vitro inhibition of the hepatitis delta virus replication mediated by interferon and trans-ribozyme or antisense probes.

V. Carreño, A. Madejón, J. Bartolomé, 1998, Journal of hepatology.

Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells

E. Domingo, C. Perales, M. E. Soria, 2023, Frontiers in Cellular and Infection Microbiology.

Hepatitis C virus-mediated Aurora B kinase inhibition modulates inflammatory pathway and viral infectivity.

E. Domingo, J. Muntané, C. Perales, 2015, Journal of hepatology.

Adsorption of polyethyleneimine on silver nanoparticles and its interaction with a plasmid DNA: a surface-enhanced Raman scattering study.

S. Sánchez‐Cortés, M. Pérez-Méndez, A. Madejón, 2002, Biomacromolecules.

Hepatitis B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to adefovir.

V. Soriano, J. Sheldon, J. García-Samaniego, 2008, The Journal of antimicrobial chemotherapy.

Clinical significance of occult hepatitis B virus infection.

C. Fernández-Rodríguez, J. García-Samaniego, A. Madejón, 2011, World journal of gastroenterology.

743 NATURALLY OCCURRING DRUG RESISTANCE MUTATIONS IN THE HEPATITIS C VIRUS NS3 PROTEASE IN HIV/HCV COINFECTED PATIENTS TREATED WITH HIV PROTEASE INHIBITORS

V. Soriano, J. García-Samaniego, P. Labarga, 2010 .

Detection of hepatitis G virus from serum and liver of a patient with long-term liver dysfunction after autologous bone marrow transplantation

A. Moreno, V. Carreño, A. Madejón, 1997, Bone Marrow Transplantation.

Detection of HDV-RNA by PCR in serum of patients with chronic HDV infection.

A. Moreno, V. Carreño, M. Melero, 1990, Journal of hepatology.

Significance of low HDV replication levels during the natural history of HDV infection. Long-term follow-up.

V. Carreño, A. Madejón, I. Castillo, 1993, Journal of hepatology.